The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fulvestrant response prediction from transcriptome data obtained from primary breast cancer biopsies.
 
Troels Dreier Christensen
No Relationships to Disclose
 
Anna Sofie Kappel Buhl
Employment - LiPlasome Pharma (I); Medical Prognosis Institute (I); Oncology Venture (I)
Leadership - Medical Prognosis Institute (I)
Stock and Other Ownership Interests - Medical Prognosis Institute; Medical Prognosis Institute (I); Oncology Venture (I); WntResearch (I)
Honoraria - LiPlasome Pharma (I); Medical Prognosis Institute
Consulting or Advisory Role - Mirrx (I)
Patents, Royalties, Other Intellectual Property - LiPlasome Pharma (I); Medical Prognosis Institute (I)
Travel, Accommodations, Expenses - LiPlasome Pharma (I); Medical Prognosis Institute (I); Oncology Venture (I)
 
Ib Jarle Christensen
No Relationships to Disclose
 
Knud Mejer Nelausen
No Relationships to Disclose
 
Eva Balslev
No Relationships to Disclose
 
Ann S. Knoop
No Relationships to Disclose
 
Eva Brix
No Relationships to Disclose
 
Peter Michael Vestlev
No Relationships to Disclose
 
Niels Henrik Hollander
No Relationships to Disclose
 
Bent Ejlertsen
No Relationships to Disclose
 
Annie Rasmussen
No Relationships to Disclose
 
Ulla Hald Buhl
Employment - LiPlasome Pharma; Medical Prognosis Institute; Oncology Venture; WntResearch
Leadership - LiPlasome Pharma; Medical Prognosis Institute; Oncology Venture
Stock and Other Ownership Interests - Medical Prognosis Institute; Oncology Venture; WntResearch
Consulting or Advisory Role - WntResearch
Patents, Royalties, Other Intellectual Property - Medical Prognosis Institute (I)
 
Anker Hansen
No Relationships to Disclose
 
Nils Brunner
No Relationships to Disclose
 
Peter Buhl Jensen
Employment - LiPlasome Pharma; Medical Prognosis Institute; Oncology Venture
Leadership - LiPlasome Pharma; Medical Prognosis Institute; Oncology Venture; WntResearch
Stock and Other Ownership Interests - Medical Prognosis Institute; Oncology Venture
Honoraria - WntResearch
Consulting or Advisory Role - WntResearch
Patents, Royalties, Other Intellectual Property - Medical Prognosis Institute
 
Steen Knudsen
No Relationships to Disclose
 
Dorte Nielsen
No Relationships to Disclose